Clinical Trial Update: Study of Adacel® Vaccine Administered to Persons 10 Years of Age [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of the Adacel vaccine in 10-year-olds with results posted, evaluating safety and immunogenicity against tetanus, diphtheria, and pertussi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• ADACEL (Tdap vaccine (tetanus, diphtheria and acellular pertussis vaccine))

Snippet

Sponsor: Sanofi | Conditions: Tetanus, Diphtheria | Phase 4 | Status: COMPLETED | Results posted: 2016-04-08